Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000037

Chief Scientific Officer bought 2,913 shares at $2.85 ($8,295)

From the SEC's structured data for this filing

Trades in this filing

Calias Pericles · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-10 Purchase : show line 1 in the form +2,913 $2.85 $8,295 52,462 D
Open-market purchases · 2,913 sh · avg $2.85 · $8,295
Loading xslF345X03/primary_doc.xml…